ES2056565T3 - Virus recombinante de la enfermedad de marek. - Google Patents

Virus recombinante de la enfermedad de marek.

Info

Publication number
ES2056565T3
ES2056565T3 ES91201796T ES91201796T ES2056565T3 ES 2056565 T3 ES2056565 T3 ES 2056565T3 ES 91201796 T ES91201796 T ES 91201796T ES 91201796 T ES91201796 T ES 91201796T ES 2056565 T3 ES2056565 T3 ES 2056565T3
Authority
ES
Spain
Prior art keywords
marek
disease
recombinant viruses
virus
protoplasm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91201796T
Other languages
English (en)
Inventor
Robin Wilson Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2056565T3 publication Critical patent/ES2056565T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION ACTUAL SE REFIERE AL USO DEL TIPO I DEL VIRUS DE LA ENFERMEDAD DE MAREK COMO VECTOR VIRAL CAPAZ DE EXPRESAR GENES EXTRAÑOS EN ALGUNAS AVES. SE RECLAMA UNA REGION DE INSERCION NO ESENCIAL DEL GENOMA DNA DEL VIRUS; UN PROTOPLASMA QUE COMPRENDE ESTA REGION; UNA CELULA HUESPED QUE CONTIENE EL PROTOPLASMA Y UNA VACUNA QUE COMPRENDE EL VIRUS RECOMBINADO.
ES91201796T 1990-07-30 1991-07-10 Virus recombinante de la enfermedad de marek. Expired - Lifetime ES2056565T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55973590A 1990-07-30 1990-07-30

Publications (1)

Publication Number Publication Date
ES2056565T3 true ES2056565T3 (es) 1994-10-01

Family

ID=24234797

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91201796T Expired - Lifetime ES2056565T3 (es) 1990-07-30 1991-07-10 Virus recombinante de la enfermedad de marek.

Country Status (11)

Country Link
EP (1) EP0473210B1 (es)
JP (1) JP3159476B2 (es)
KR (1) KR0153005B1 (es)
CN (1) CN1056879C (es)
AU (1) AU645333B2 (es)
CA (1) CA2047290C (es)
DE (1) DE69101683T2 (es)
ES (1) ES2056565T3 (es)
HU (1) HU219377B (es)
NZ (1) NZ239146A (es)
ZA (1) ZA915563B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
EP0750670A1 (en) * 1994-02-07 1997-01-02 Cornell Research Foundation, Inc. Compositions useful in controlling marek's disease
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
CA2216139C (en) * 1995-03-23 2013-01-08 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
NZ309172A (en) * 1995-06-07 1999-11-29 Leadd B Neutralizing conformational epitopes of chicken anemia virus
FR2767335B1 (fr) * 1997-08-14 2001-09-28 Ct Nat D Etudes Veterinaires E Adenovirus aviaire celo recombinant comme vecteur vaccinant
ES2360225T3 (es) 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
WO2004018683A1 (en) 2002-08-12 2004-03-04 Akzo Nobel N.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
CN100334217C (zh) * 2005-08-15 2007-08-29 北京市农林科学院 重组鸡马立克氏病病毒转移载体及应用
EP2412382A1 (en) 2010-07-29 2012-02-01 University Court of the University of Edinburgh Recombinant Trypanosoma theileri parasite
US9139824B2 (en) 2011-04-21 2015-09-22 The University Court Of The University Of Aberdeen Sapolegina protein in for use as a medicament
ES2717441T3 (es) 2012-10-09 2019-06-21 Univ Gent Vacuna contra Cooperia
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) * 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
CN118703704A (zh) * 2024-07-22 2024-09-27 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种用于鉴别表达ibdv vp2基因的重组mdv疫苗株的引物、试剂盒、方法及其应用
CN119842636A (zh) * 2025-03-18 2025-04-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 表达血清4型禽腺病毒Fiber2基因的重组马立克氏病病毒及其构建方法和应用
CN119842637A (zh) * 2025-03-18 2025-04-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 表达IBDV VP2和FAdV-4 Fiber2基因的重组马立克氏病病毒及其构建方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
EP0431668B1 (en) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE

Also Published As

Publication number Publication date
KR920002782A (ko) 1992-02-28
ZA915563B (en) 1992-07-29
CN1060680A (zh) 1992-04-29
JPH06233682A (ja) 1994-08-23
DE69101683T2 (de) 1994-07-21
HU219377B (en) 2001-03-28
AU8143791A (en) 1992-02-06
EP0473210A2 (en) 1992-03-04
DE69101683D1 (de) 1994-05-19
CA2047290C (en) 2002-12-10
KR0153005B1 (ko) 1998-10-15
JP3159476B2 (ja) 2001-04-23
HUT58371A (en) 1992-02-28
CN1056879C (zh) 2000-09-27
EP0473210A3 (en) 1992-06-10
HU912526D0 (en) 1992-01-28
AU645333B2 (en) 1994-01-13
NZ239146A (en) 1992-12-23
EP0473210B1 (en) 1994-04-13
CA2047290A1 (en) 1992-01-31

Similar Documents

Publication Publication Date Title
ES2056565T3 (es) Virus recombinante de la enfermedad de marek.
ES2070997T3 (es) Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
ES2145000T3 (es) Virus recombinante del avipox.
DE69125925D1 (de) Rekombinante herpes simplex virus impfstoffe und methoden
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DK0596979T3 (da) Rekombinante nucleinsyrer fra plantevirus
BR9712592A (pt) Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
DK605987D0 (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
BR0014171A (pt) Composição
JPS6479124A (en) Factor viii analogue, manufacture and medicine
EP0261940A3 (en) Pseudorabies vaccines and dna vectors for recombination with pox viruses
DE68920610D1 (de) Rekombinantes Virus der Marekschen Krankheit und Vakzin.
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
PT84640B (pt) Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas
FR2445338A1 (fr) Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennent
ES2131050T3 (es) Genes de resistencia a virus/herbicidas, procedimiento para su preparacion y su uso.
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
ES8900170A1 (es) Procedimiento de modificacion de celulas eucariotas.
DK1071758T3 (da) Porcin adenovirus-vektor
ES2188589T3 (es) Vacuna recombinante del herpes virus felino.
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
MX9602256A (es) Vacuna contra la enfermedad de marek.
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
FR2693472B1 (fr) Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
ES2060625T3 (es) Virus de papiloma humano del tipo 41.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 473210

Country of ref document: ES